Last Posted: Aug 01, 2019
- Recent Advances in Lung Cancer Immunotherapy: Input of T-Cell Epitopes Associated With Impaired Peptide Processing.
Leclerc Marine et al. Frontiers in immunology 2019 1505 - Circulating tumor cells in patients with lung cancer: developments and applications for precision medicine.
Tong Bing et al. Future oncology (London, England) 2019 Jul - Brief Report: Prevalence and Preliminary Validation of Screening Criteria to Identify Carriers of Germline BAP1 Mutations.
Zauderer Marjorie G et al. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2019 Jul - Circulating tumor DNA detection is correlated to histologic types in patients with early-stage non-small-cell lung cancer.
Zhang Bin et al. Lung cancer (Amsterdam, Netherlands) 2019 Aug 134108-116 - Clinical utility of plasma-based digital next-generation sequencing in oncogene-driven non-small-cell lung cancer patients with tyrosine kinase inhibitor resistance.
Zugazagoitia Jon et al. Lung cancer (Amsterdam, Netherlands) 2019 Aug 13472-78 - Identification and monitoring of somatic mutations in circulating cell-free tumor DNA in lung cancer patients.
Francaviglia Ilaria et al. Lung cancer (Amsterdam, Netherlands) 2019 Aug 134225-232 - Identification of risk loci and a polygenic risk score for lung cancer: a large-scale prospective cohort study in Chinese populations.
Dai Juncheng et al. The Lancet. Respiratory medicine 2019 Jul - Opportunities of circulating tumor DNA in lung cancer.
Wu Ting-Hui et al. Cancer treatment reviews 2019 Jul 7831-41 - Screening for Anaplastic Lymphoma Kinase (ALK) gene rearrangements in non-small cell lung cancer (NSCLC) in New Zealand.
McKeage Mark James et al. Internal medicine journal 2019 Jul - Sensitivity of next-generation sequencing assays detecting oncogenic fusions in plasma cell-free DNA.
Supplee Julianna G et al. Lung cancer (Amsterdam, Netherlands) 2019 Aug 13496-99
No hay comentarios:
Publicar un comentario